Afelimomab - CISMeF

Preferred Label : Afelimomab;

UNII : 6SC756X51V;

CAS number : 156227-98-4; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 156227-98-4 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

NCI Metathesaurus CUI : CL972208;

Details

Origin ID

C166960;

UMLS CUI

C0966666;

Automatic exact mappings (from CISMeF team)
- Afelimomab [ICD-11 Extension code]
Currated CISMeF NLP mapping
- afelimomab [MeSH Supplementary Concept]
- afelimomab [MeSH concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- afelimomab [ATC Code]
- afelimomab [MeSH Supplementary Concept]
- afelimomab [MeSH concept]
Validated automatic mappings to BTNT
- afelimomab [ATC Code]
chemical_or_drug_has_mechanism_of_action
- Antigen Binding [NCIt concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients